The role of community pharmacists in depression management: a survey of attitudes, practices and perceived barriers

被引:0
作者
Rula Shami
Mohammed Fasihul Alam
Maguy Saffouh ElHajj
机构
[1] QU Health,Department of Public Health, College of Health Sciences
[2] Qatar University,College of Pharmacy
[3] QU Health,undefined
[4] Qatar University,undefined
来源
International Journal of Clinical Pharmacy | 2022年 / 44卷
关键词
Attitude; Barrier; Community pharmacist; Depression; Practice;
D O I
暂无
中图分类号
学科分类号
摘要
Background Community pharmacists play a significant role in depression care. Depression is a health priority in national health strategies around the world, including in Qatar. Objective To describe current practices, attitudes and perceived barriers of community pharmacists towards depression care, and to investigate factors associated with these practices. Setting Community pharmacies in Qatar. Method A cross-sectional online survey using an adapted survey instrument. Scores were measured on a five-point Likert scale. Descriptive univariate and bivariate analyses of study outcomes, followed by multivariate regression examining the association between pharmacists’ practices and their attitudes, socio-demographic and professional characteristics. Main outcome measure Pharmacists’ scores on self-reported attitudes towards depression and depression care practices and the number of perceived barriers for depression care. Result: 358 pharmacists (response rate 39%) completed the questionnaire. Pharmacists’ attitudes to depression were moderately positive (mean score = 3.41, SD = 0.26) but involvement in depression care was very low (mean score = 2.64, SD = 0.94). Three major barriers were lack of access to patients’ medical records (83.21%), lack of patients’ insight on depression and the importance of treatment (81.85%), and lack of knowledge and training on mental health (79.63%). Female pharmacists and those graduated more than 10 years prior were significantly less involved in depression care compared to their counterparts (practice scores (95% CI) −4.36 (−7.46 to −1.26) and -7.51 (−15.10 to −1.35), respectively), while those who had access to private counselling area were more involved (practice score 3.39 (0.20 to 6.59). Pharmacists’ depression practice score was positively associated with attitudes (p = 0.001). Conclusion Pharmacists’ moderately positive attitudes were not reflected in their suboptimal depression-care practices. Action from policymakers is needed to improve pharmacists’ practices and attitudes to depression.
引用
收藏
页码:214 / 226
页数:12
相关论文
共 194 条
  • [1] Zolezzi M(2018)Stigma associated with mental illness and its treatment in the Arab culture: A systematic review Int J Soc Psychiatry 64 597-609
  • [2] Alamri M(2004)The treatment gap in mental health care Bull World Health Organ 82 858-866
  • [3] Shaar S(2015)The prevalence and burden of psychiatric disorders in primary health care visits in qatar: too little time? J Family Med Prim Care 4 89-95
  • [4] Rainkie D(2015)Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines J Psychopharmacol 29 459-525
  • [5] Kohn R(2015)Duration of initial antidepressant treatment and subsequent relapse of major depression J Clin Psychopharmacol 35 75-76
  • [6] Saxena S(2000)Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence Arch Intern Med 160 2101-2107
  • [7] Levav I(2007)Chronic disease management for depression in primary care: a summary of the current literature and implications for practice Can J Psychiatry 52 77-85
  • [8] Saraceno B(2004)Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care Am J Health Syst Pharm 61 364-372
  • [9] Bener A(2018)The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes J Ment Health 27 164-173
  • [10] Abou-Saleh MT(2003)Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trial Eur Neuropsychopharmacol 13 1-9